TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Blood transfusion during perioperative period in patients undergoing to major surgery has been associated to several postoperative complications. Particularly in oncologic surgery, red blood cell transfusion has been investigated as a factor of worse outcome and cancer recurrence due to postoperative impairment of cellular immunity. Although red blood cell transfusion has decreased in worldwide clinical practice, this issue still remains a matter of controversy in oncologic surgery. There are no prospective studies comparing outcomes between restrictive or liberal of blood transfusion strategy in oncologic surgery. This study is a prospective and randomized study comparing clinical outcomes between two strategies of transfusion in oncologic surgery - liberal or restrictive


Options:
A: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Liberal Transfusion Strategy | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Restrictive Transfusion Strategy
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
C: Arm Label: Blood transfusion triggers of 24% hematocrit value; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood transfusion at hematocrit value less than 24% | Arm Label: Blood transfusion triggers of 28% hematocrit value; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood transfusion at hematocrit value less than 28% | Intervention Type: PROCEDURE; Name: Blood transfusion at hematocrit value less than 24%; Assigned to Arm(s): Blood transfusion triggers of 24% hematocrit value | Intervention Type: PROCEDURE; Name: Blood transfusion at hematocrit value less than 28%; Assigned to Arm(s): Blood transfusion triggers of 28% hematocrit value
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: FE; Type: EXPERIMENTAL; Interventions: Drug: Ferric carboxymaltose | Arm Label: EPOFE; Type: EXPERIMENTAL; Interventions: Drug: Ferric carboxymaltose, Drug: Erythropoietin | Intervention Type: DRUG; Name: Ferric carboxymaltose; Assigned to Arm(s): EPOFE, FE | Intervention Type: DRUG; Name: Erythropoietin; Assigned to Arm(s): EPOFE | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Temozolomid (One Week on/One Week Off) Versus Strahlentherapie in Der Primärtherapie Anaplastischer Astrozytome Und Glioblastome Bei älteren Patienten: Eine Randomisierte Phase III-Studie (Methvsalem)
Brief Summary: The study aims to optimize the treatment of elderly subjects (\> 65) with anaplastic astrocytoma and glioblastoma. Current treatment policies tend to be no more than palliative. There is no consensus as to how radical the surgery should be. Involved-field radiotherapy is the treatment most likely to be accepted apart from supportive and palliative measures. The role of chemotherapy is barely defined. Study data available to date does not suggest that this patient population would benefit from combined radiochemotherapy. The aim of the study is to verify the hypothesis that first-line chemotherapy with one week on/one week off temozolomide is not inferior to extended-field radiotherapy in the first-line treatment of anaplastic astrocytoma and glioblastoma in the elderly (\> 65 age group). The primary endpoint is median survival, as life expectancy is limited to several months. Secondary endpoints are response rates in both arms (CR, PR, MacDonald et al. 1990), median progression-free survival, 1-year and 2-year survival rates, definition of MGMT as molecular genetic prognostic or predictive markers, and quality of life. Theoretically, it should be possible to preserve quality of life in the first-line chemotherapy arm of the study.


Options:
A: Arm Label: Temozolomide; Type: ACTIVE_COMPARATOR; Interventions: Drug: temozolomide, Genetic: DNA methylation analysis, Procedure: quality-of-life assessment | Arm Label: Radiation; Type: ACTIVE_COMPARATOR; Interventions: Genetic: DNA methylation analysis, Procedure: quality-of-life assessment, Radiation: Radiation | Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): Temozolomide | Intervention Type: GENETIC; Name: DNA methylation analysis; Assigned to Arm(s): Radiation, Temozolomide | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): Radiation, Temozolomide | Intervention Type: RADIATION; Name: Radiation; Assigned to Arm(s): Radiation
B: Arm Label: Radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Radiotherapy of the partial brain. | Arm Label: Temozolomide; Type: EXPERIMENTAL; Interventions: Drug: Temozolomide | Intervention Type: DRUG; Name: Temozolomide; Assigned to Arm(s): Temozolomide | Intervention Type: RADIATION; Name: Radiotherapy of the partial brain.; Assigned to Arm(s): Radiotherapy
C: Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: lomustine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: procarbazine hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vincristine sulfate; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patients' Knowledge and Understanding of Cancer Clinical Trials - a Randomised Study of Audio Recorded Information
Brief Summary: The purpose of this study is to test if cancer patients who are informed about, and offered participation in a cancer clinical trial, are more knowledgeable about cancer clinical trials if they have access to an audio recording of their information visit.


Options:
A: Arm Label: Copy of audio recording; Type: EXPERIMENTAL; Interventions: Other: audio recorded information | Arm Label: No copy of audio recording; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: audio recorded information; Assigned to Arm(s): Copy of audio recording
B: Intervention Type: DRUG; Name: hormone replacement therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogens; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: progestins; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogen replacement therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: calcium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vitamin D; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: dietary supplements; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: VRC-AViDNA036-00-VP; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: VRC-FLUDNA047-00-VP; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Flulaval (Registered) Seasonal Influenza Vaccine; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Translation of Comparative Effectiveness of Depression Medications Into Practice
Brief Summary: The purpose of this study is to determine whether the Depression Medication Choice decision aid is effective in involving patients with depression in making deliberate choices when considering medication treatment.


Options:
A: Arm Label: Patient Decision Aid for an ICD (primary prevention, non-CRT); Type: EXPERIMENTAL; Interventions: Behavioral: Patient Decision Aid for an ICD (primary prevention, non-CRT) | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Patient Decision Aid for an ICD (primary prevention, non-CRT); Assigned to Arm(s): Patient Decision Aid for an ICD (primary prevention, non-CRT)
B: Arm Label: RQP-MH; Type: EXPERIMENTAL; Interventions: Behavioral: Right Question Project - Mental Health (RQP-MH) | Arm Label: Comparison Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Pamphlet | Intervention Type: BEHAVIORAL; Name: Right Question Project - Mental Health (RQP-MH); Assigned to Arm(s): RQP-MH | Intervention Type: BEHAVIORAL; Name: Pamphlet; Assigned to Arm(s): Comparison Group
C: Arm Label: Adaptive Conjoint Analysis; Type: EXPERIMENTAL; Interventions: Other: Adaptive Conjoint Analysis | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Adaptive Conjoint Analysis; Assigned to Arm(s): Adaptive Conjoint Analysis
D: Arm Label: Decision aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Decision Aid | Arm Label: Normal care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision aid

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Translation of Comparative Effectiveness of Depression Medications Into Practice
Brief Summary: The purpose of this study is to determine whether the Depression Medication Choice decision aid is effective in involving patients with depression in making deliberate choices when considering medication treatment.


Options:
A: Arm Label: Decision aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Decision Aid | Arm Label: Normal care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision aid
B: Arm Label: Intervention Patients & Providers; Type: EXPERIMENTAL; Interventions: Behavioral: DECIDE-PA | Arm Label: Intervention Patients, Control Providers; Type: EXPERIMENTAL; Interventions: Behavioral: DECIDE-PA | Arm Label: Control Patients, Intervention Providers; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control Patients & Providers; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-Randomized Controlled Trial Patients; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control Providers; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Providers; Type: EXPERIMENTAL; Interventions: Behavioral: DECIDE-PC | Intervention Type: BEHAVIORAL; Name: DECIDE-PA; Assigned to Arm(s): Intervention Patients & Providers, Intervention Patients, Control Providers | Intervention Type: BEHAVIORAL; Name: DECIDE-PC; Assigned to Arm(s): Intervention Providers
C: Arm Label: multi-faceted decision support; Type: EXPERIMENTAL; Interventions: Other: Clinical decision support | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: stream-lined clinical alert | Intervention Type: OTHER; Name: Clinical decision support; Assigned to Arm(s): multi-faceted decision support | Intervention Type: OTHER; Name: stream-lined clinical alert; Assigned to Arm(s): control
D: Arm Label: CBT no choice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: CBT choice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: sertraline no choice; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline | Arm Label: sertraline choice; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): sertraline choice, sertraline no choice | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy (CBT); Assigned to Arm(s): CBT choice, CBT no choice

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Translation of Comparative Effectiveness of Depression Medications Into Practice
Brief Summary: The purpose of this study is to determine whether the Depression Medication Choice decision aid is effective in involving patients with depression in making deliberate choices when considering medication treatment.


Options:
A: Arm Label: Decision Aid; Type: EXPERIMENTAL; Interventions: Other: Decision Aid | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision Aid
B: Arm Label: Depression Self-care Intervention (SCI); Type: EXPERIMENTAL; Interventions: Behavioral: Depression self-care | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Depression self-care; Assigned to Arm(s): Depression Self-care Intervention (SCI)
C: Arm Label: Decision aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Decision Aid | Arm Label: Normal care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision aid
D: Arm Label: PCI Choice decision; Type: ACTIVE_COMPARATOR; Interventions: Other: Decision Aid | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): PCI Choice decision

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain: A Longitudinal Randomized Controlled Trial
Brief Summary: The aim of this study is to find out the effects of routinely using different types of pain-relieving strategies during routine immunization injections performed in infants.


Options:
A: Arm Label: Massage; Type: EXPERIMENTAL; Interventions: Behavioral: massage | Arm Label: Quiet Time; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: quiet time | Intervention Type: BEHAVIORAL; Name: massage; Assigned to Arm(s): Massage | Intervention Type: BEHAVIORAL; Name: quiet time; Assigned to Arm(s): Quiet Time
B: Arm Label: Group 1; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Educational Video - Sham, Drug: Sucrose Placebo (water), Drug: Lidocaine Placebo | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational video - Active, Drug: Sucrose Placebo (water), Drug: Lidocaine Placebo | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational video - Active, Drug: Sucrose, Drug: Lidocaine Placebo | Arm Label: Group 4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational video - Active, Drug: Sucrose, Drug: Lidocaine | Intervention Type: BEHAVIORAL; Name: Educational video - Active; Assigned to Arm(s): Group 2, Group 3, Group 4 | Intervention Type: BEHAVIORAL; Name: Educational Video - Sham; Assigned to Arm(s): Group 1 | Intervention Type: DRUG; Name: Sucrose Placebo (water); Assigned to Arm(s): Group 1, Group 2 | Intervention Type: DRUG; Name: Sucrose; Assigned to Arm(s): Group 3, Group 4 | Intervention Type: DRUG; Name: Lidocaine Placebo; Assigned to Arm(s): Group 1, Group 2, Group 3 | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Group 4
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: pillow | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: pillow; Assigned to Arm(s): 1
D: Arm Label: control; Type: N/A; Interventions: N/A | Arm Label: sucrose; Type: N/A; Interventions: N/A | Arm Label: physical intervention; Type: N/A; Interventions: N/A | Arm Label: physical intervention and sucrose; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Noninvasive Brain Stimulation for Stroke Improvement
Brief Summary: Noninvasive brain stimulations will be used in acute and chronic stroke patients to improve a variety of functions.


Options:
A: Arm Label: tDCS plus wrist robot therapy; Type: EXPERIMENTAL; Interventions: Device: tDCS plus wrist robot therapy | Arm Label: Sham tDCS plus wrist robot therapy; Type: SHAM_COMPARATOR; Interventions: Device: Sham tDCS plus wrist robot therapy | Intervention Type: DEVICE; Name: tDCS plus wrist robot therapy; Assigned to Arm(s): tDCS plus wrist robot therapy | Intervention Type: DEVICE; Name: Sham tDCS plus wrist robot therapy; Assigned to Arm(s): Sham tDCS plus wrist robot therapy
B: Arm Label: sham and then anodal; Type: EXPERIMENTAL; Interventions: Device: anodal tDCS and sham tDCS stimulations | Arm Label: anodal and then sham; Type: EXPERIMENTAL; Interventions: Device: anodal tDCS and sham tDCS stimulations | Intervention Type: DEVICE; Name: anodal tDCS and sham tDCS stimulations; Assigned to Arm(s): anodal and then sham, sham and then anodal
C: Arm Label: tDCS & epidermis anesthesia & repeated passive movement; Type: EXPERIMENTAL; Interventions: Device: tDCS, Drug: Epidermis anesthesia, Other: Repeated passive movement | Arm Label: Shame tDCS & sham anesthesia & repeated passive movement; Type: SHAM_COMPARATOR; Interventions: Drug: sham anesthesia, Other: Repeated passive movement, Device: sham tDCS | Intervention Type: DEVICE; Name: tDCS; Assigned to Arm(s): tDCS & epidermis anesthesia & repeated passive movement | Intervention Type: DRUG; Name: Epidermis anesthesia; Assigned to Arm(s): tDCS & epidermis anesthesia & repeated passive movement | Intervention Type: DRUG; Name: sham anesthesia; Assigned to Arm(s): Shame tDCS & sham anesthesia & repeated passive movement | Intervention Type: OTHER; Name: Repeated passive movement; Assigned to Arm(s): Shame tDCS & sham anesthesia & repeated passive movement, tDCS & epidermis anesthesia & repeated passive movement | Intervention Type: DEVICE; Name: sham tDCS; Assigned to Arm(s): Shame tDCS & sham anesthesia & repeated passive movement
D: Arm Label: Real stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Arm Label: Sham stimulation; Type: SHAM_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Intervention Type: DEVICE; Name: tdcs (ELDITH, Neuroconn, Ilmenau, Germany); Assigned to Arm(s): Real stimulation, Sham stimulation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Noninvasive Brain Stimulation for Stroke Improvement
Brief Summary: Noninvasive brain stimulations will be used in acute and chronic stroke patients to improve a variety of functions.


Options:
A: Arm Label: tDCS + physical therapy; Type: EXPERIMENTAL; Interventions: Device: tDCS + physical therapy | Arm Label: Sham tDCS + physical therapy; Type: SHAM_COMPARATOR; Interventions: Device: tDCS + physical therapy | Intervention Type: DEVICE; Name: tDCS + physical therapy; Assigned to Arm(s): Sham tDCS + physical therapy, tDCS + physical therapy
B: Arm Label: Sham; Type: PLACEBO_COMPARATOR; Interventions: Device: tDCS | Arm Label: tDCS; Type: EXPERIMENTAL; Interventions: Device: tDCS | Intervention Type: DEVICE; Name: tDCS; Assigned to Arm(s): Sham, tDCS
C: Arm Label: RBX + tDCS; Type: EXPERIMENTAL; Interventions: Drug: reboxetine, Device: tDCS verum | Arm Label: RBX + sham stimulation; Type: ACTIVE_COMPARATOR; Interventions: Drug: reboxetine, Device: tDCS sham | Arm Label: PLC + tDCS; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Device: tDCS verum | Arm Label: PLC + sham stimulation; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo, Device: tDCS sham | Intervention Type: DRUG; Name: reboxetine; Assigned to Arm(s): RBX + sham stimulation, RBX + tDCS | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): PLC + sham stimulation, PLC + tDCS | Intervention Type: DEVICE; Name: tDCS verum; Assigned to Arm(s): PLC + tDCS, RBX + tDCS | Intervention Type: DEVICE; Name: tDCS sham; Assigned to Arm(s): PLC + sham stimulation, RBX + sham stimulation
D: Arm Label: Real stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Arm Label: Sham stimulation; Type: SHAM_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Intervention Type: DEVICE; Name: tdcs (ELDITH, Neuroconn, Ilmenau, Germany); Assigned to Arm(s): Real stimulation, Sham stimulation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Bioefficacy of Vitamin D2 and Vitamin D3: Randomized Trial With Human Volunteers
Brief Summary: The aim of this study is to investigate the bioavailability of vitamin D2 and D3 as measured by the increase of the specific hydroxy forms in serum (25(OH)D2 and 25(OH)D3, respectively, and by total 25(OH)D.


Options:
A: Arm Label: Intervention; Type: N/A; Interventions: Behavioral: educational/counseling intervention, Behavioral: therapeutic dietary intervention | Arm Label: Control; Type: N/A; Interventions: Behavioral: therapeutic dietary intervention | Intervention Type: BEHAVIORAL; Name: educational/counseling intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: therapeutic dietary intervention; Assigned to Arm(s): Control, Intervention
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: cholecalciferol (vitamin D) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: cholecalciferol (vitamin D) | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D); Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D); Assigned to Arm(s): 2
C: Arm Label: Full Factorial Placebo; Type: EXPERIMENTAL; Interventions: Drug: placebo | Arm Label: Full Factorial Calcium; Type: EXPERIMENTAL; Interventions: Drug: Calcium Carbonate | Arm Label: Full Factorial Vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 | Arm Label: Full Factorial Calcium Plus Vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Calcium Carbonate, Drug: Vitamin D3 | Arm Label: Two Arm Placebo; Type: EXPERIMENTAL; Interventions: Drug: Calcium Carbonate | Arm Label: Two Arm Vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Calcium Carbonate, Drug: Vitamin D3 | Intervention Type: DRUG; Name: Calcium Carbonate; Assigned to Arm(s): Full Factorial Calcium, Full Factorial Calcium Plus Vitamin D, Two Arm Placebo, Two Arm Vitamin D | Intervention Type: DRUG; Name: Vitamin D3; Assigned to Arm(s): Full Factorial Calcium Plus Vitamin D, Full Factorial Vitamin D, Two Arm Vitamin D | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Full Factorial Placebo
D: Arm Label: cholecalciferol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol | Arm Label: Ergocalciferol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: ergocalciferol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol; Assigned to Arm(s): cholecalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: ergocalciferol; Assigned to Arm(s): Ergocalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D